Skip to main content
SpringerLink
Log in

Acute Renal Failure Probably Induced by Prulifloxacin in an Elderly Woman

A First Case Report

  • Case Report
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II

References

  1. Ozaki M, Matsuda M, Tomii Y, et al. In vivo evaluation of NM441, a new thiazeto-quinoline derivative. Antimicrob Agents Chemother 1991; 35: 2496–9

    Article  PubMed  CAS  Google Scholar 

  2. Grassi C, Salvatori E, Rosignoli MT, et al. Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis. Respiration 2002; 69: 217–22

    Article  PubMed  CAS  Google Scholar 

  3. Reato G, Cuffini AM, Tullio V, et al. Immunomodulating effect of antimicrobial agents on cytokine production by human polymorphonuclear neutrophils. Int J Antimicrob Agents 2004; 23: 150–4

    Article  PubMed  CAS  Google Scholar 

  4. Tullio V, Cuffini AM, Bonino A, et al. Influence of a new fluoroquinolone, AF3013 (the active metabolite of prulifloxacin) on macrophage functions against Klebsiella pneumoniae: an in vitro comparison with pefloxacin. J Antimicrob Chemother 2000; 46: 241–7

    Article  PubMed  CAS  Google Scholar 

  5. 5. Angelini ACRAF SpA. Investigator’s brochure: Unidrox. prulifloxacin 600mg tablets. Rome: ACRAF SpA, 2004

    Google Scholar 

  6. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–45

    Article  PubMed  CAS  Google Scholar 

  7. Grossman RF. Guidelines for the treatment of acute exacerbation of chronic bronchitis. Chest 1997; 112: 310S–3S

    Article  PubMed  CAS  Google Scholar 

  8. Balter MS, La Forge J, Low DE, et al. Canadian guidelines for the management of acute exacerbations of chronic bronchitis: executive summary. Can Respir J 2003; 10: 248–58

    PubMed  Google Scholar 

  9. Mandell LA, Bartlett JG, Dowell SF, et al. Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003; 37: 1405–33

    Article  PubMed  Google Scholar 

  10. Gallelli L, Del Negro S, Naty S, et al. Levofloxacin-induced taste perversion, blurred vision and dyspnoea in a young woman. Clin Drug Invest 2004; 24: 487–9

    Article  Google Scholar 

  11. Kawaminami A, Tawaratani T, Ishibashi S, et al. Renal toxicity of prulifloxacin (NM441) in rats. J Toxicol Sei 1996; 21: 267–76

    Article  CAS  Google Scholar 

  12. Singh AK, Ucci A, Madias NE. Predominant tubulointerstitial lupus nephritis. Am J Kidney Dis 1996; 27: 273–8

    Article  PubMed  CAS  Google Scholar 

  13. Townend BS, Sturm JW, Whyte S. Quinine associated blindness. Aust Fam Physician 2004; 33: 627–8

    PubMed  Google Scholar 

  14. Reddy JC, Shuman MA, Aster RH. Quinine/quinidine-induced thrombocytopenia: a great imitator. Arch Intern Med. 2004; 164: 218–20

    Article  PubMed  Google Scholar 

  15. Pawar R, Jacobs GH, Smith C. Quinine-associated acute interstitial nephritis. Am J Kidney Dis. 1994; 24: 211–4

    PubMed  CAS  Google Scholar 

  16. Muller M, Strand S, Hug H, et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 1997; 99: 403

    Article  PubMed  CAS  Google Scholar 

  17. Faubion WA, Guicciardi ME, Miyoshi H, et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 1999; 103: 137–45

    Article  PubMed  CAS  Google Scholar 

  18. Zhang H, Cook J, Nickel J, et al. Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis. Nat Biotechnol 2000; 18: 862–7

    Article  PubMed  CAS  Google Scholar 

  19. Zinszner H, Kuroda M, Wang XZ, et al. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 1998; 12: 982–95

    Article  PubMed  CAS  Google Scholar 

  20. Lorz C, Justo P, Sanz A, et al. Paracetamol-induced renal tubular injury: a role for ER stress. J Am Soc Nephrol 2004; 15: 380–9

    Article  PubMed  CAS  Google Scholar 

  21. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 2000; 11: 319–29

    PubMed  CAS  Google Scholar 

  22. Silbiger SR, Neugarten J. The role of gender in the progression of renal disease. Adv Ren Replace Ther 2003; 10: 3–14

    Article  PubMed  Google Scholar 

  23. Kang DH, Yu ES, Yoon Kl, et al. The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. Am J Pathol 2004; 164: 679–88

    Article  PubMed  CAS  Google Scholar 

  24. Lipsky BA, Baker CA. Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin Infect Dis 1999; 28: 352–64

    Article  PubMed  CAS  Google Scholar 

  25. Hootkins R, Fenves AZ, Stephens MK. Acute renal failure secondary to oral ciprofloxacin therapy: a presentation of three cases and a review of the literature. Clin Nephrol 1989; 32: 75–8

    PubMed  CAS  Google Scholar 

  26. Allon M, Lopez EJ, Min KW. Acute renal failure due to ciprofloxacin. Arch Intern Med 1990; 150: 2187–9

    Article  PubMed  CAS  Google Scholar 

  27. Malhotra S, Karan RS, Pandhi P, et al. Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 2001; 77: 703–7

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study received no funding, and the authors have no conflicts of interest that are directly relevant to the contents of this article.

Author information

Authors and Affiliations

  1. Clinical Pharmacology and Pharmacovigilance Unit, Department of Experimental and Clinical Medicine, Faculty of Medicine and Surgery University ‘Magna Graecia’ of Catanzaro, ‘Mater Domini’ University Hospital, Via T. Campanella 115, 88100, Catanzaro, Italy

    L. Gallelli & G. De Sarro

  2. Department of Experimental and Clinical Medicine, Chair of Respiratory Diseases, Faculty of Medicine and Surgery University ‘Magna Graecia’ of Catanzaro, ‘Mater Domini’ University Hospital, Catanzaro, Italy

    A. Gallelli, G. Veto, F. Roccia, G. Pelaia & R. Maselli

Authors
  1. L. Gallelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Gallelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Veto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Roccia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Pelaia
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. De Sarro
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Maselli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Gallelli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gallelli, L., Gallelli, A., Veto, G. et al. Acute Renal Failure Probably Induced by Prulifloxacin in an Elderly Woman. Clin. Drug Investig. 26, 49–53 (2006). https://doi.org/10.2165/00044011-200626010-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200626010-00007

Keywords

Search

Navigation